Artificial Intelligence In Cancer Treatment: Understanding Current Applications And Future Possibilities

Data sources, quality, and workflow integration for AI in cancer care

Key data sources for oncology AI include imaging archives, pathology slide scans, genomic sequencing output, and electronic health record data. Each data type brings specific quality challenges: imaging may vary by scanner and protocol, pathology annotations require domain expertise, and genomic data needs standardized pipelines for variant calling. Data curation steps such as harmonizing formats, removing personally identifiable information, and ensuring consistent labeling are often necessary before model training. Teams typically document preprocessing steps to support reproducibility and later auditability.

Annotation quality strongly influences supervised model performance. Expert annotations for lesions or histologic features may be time-consuming and variable across raters. Approaches to improve annotation utility include consensus labeling, multi-reader aggregation, and the use of annotation tools that capture uncertainty. Where annotations are scarce, weak supervision or active learning methods may be explored to make efficient use of available expert time, though these strategies usually require careful validation to quantify introduced biases.

Interoperability and workflow integration determine practical utility. Models that output results in formats compatible with picture archiving and communication systems (PACS), pathology viewers, or clinical decision support modules are more likely to be reviewed by clinical teams. Considerations such as latency, user interface clarity, and alignment with clinician information needs often surface during pilot implementations. Teams commonly plan iterative refinements based on clinician feedback to improve adoption potential while ensuring data governance and security requirements are met.

Data governance and bias mitigation are central concerns. Datasets that lack demographic or clinical diversity may produce models that perform unevenly across subgroups. Strategies to address this concern include stratified validation, external testing on independent cohorts, and transparent reporting of dataset composition. Privacy-preserving techniques such as federated learning or secure multi-party computation may be considered when pooling data across institutions is constrained by legal or ethical considerations, although these approaches bring their own technical and validation challenges.